New Target Request. When Isis wishes to add a new Gene Target to occupy a vacant DS-Target Slot, it will provide Alnylam with written notice (the “Request Notice”) of the Gene Target it wishes to add (the “Proposed Reserved DS-Target”). The Request Notice will include the gene name, and the NCBI accession number or nucleic acid sequence for the Proposed Reserved DS-Target.
Appears in 2 contracts
Samples: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Strategic Collaboration and License Agreement (Isis Pharmaceuticals Inc)
New Target Request. When Isis wishes to add a new Gene Target to occupy a vacant DS-Target Slot, it will provide Alnylam with written notice (the “"Request Notice”") of the Gene Target it wishes to add (the “"Proposed Reserved DS-Target”"). The Request Notice will include the gene name, and the NCBI accession number or nucleic acid sequence for the Proposed Reserved DSTarget and whether Isis wants the Proposed Reserved Target, if accepted, to be an Isis Exclusive Target or an Isis Co-Exclusive Target.
Appears in 2 contracts
Samples: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals Inc), Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals Inc)
New Target Request. When Isis wishes to add a new Gene RNA Target to occupy a vacant DS-Target Slot, it will provide Alnylam with written notice (the “Request Notice”) of the Gene RNA Target it wishes to add (the “Proposed Reserved DS-Target”). The Request Notice will include the gene name, and the NCBI accession number or nucleic acid sequence for the Proposed Reserved DS-Target.
Appears in 2 contracts
Samples: Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Strategic Collaboration and License Agreement (Isis Pharmaceuticals Inc)
